hrp0097p2-11 | Growth and Syndromes | ESPE2023

GH-IGF-1 axis in PTPN11 and non-PTPN11 Noonan syndrome: Effects on growth and response to GH treatment

Jírová Barbora , Kodytková Aneta , Dušátková Petra , Koloušková Stanislava , Obermannová Barbora , Průhová Štěpánka , Šnajderová Marta , Šumník Zdeněk , Lebl Jan

Introduction: The mechanisms underlying short stature in Noonan Syndrome (NS) are poorly understood and may include inadequate GH secretion or action, decreased IGF-1 production, growth plate dysfunction, or other factors. In this retrospective study, we aimed to evaluate the function of the GH-IGF-1 axis in NS.Method: We took all patients with genetically proven Noonan syndrome among 1001 children and adolescents curren...

hrp0098fc7.2 | GH and IGFs | ESPE2024

Stratifying genetic etiology in children born small for gestational age with persistent short stature (SGA-SS): 5-year growth hormone (GH) treatment outcomes in genetic subgroups

Jírová Barbora , Toni Ledjona , Dušátková Petra , Amaratunga Shenali , Jeřábek Filip , Obermannová Barbora , Koloušková Stanislava , Průhová Štěpánka , Šnajderová Marta , Šumník Zdeněk , Plachý Lukáš , Lebl Jan

Background: The genetic etiology of SGA-SS spans from abnormalities of the GH-IGF-1 axis, growth plate disorders, and defective fundamental intracellular/intranuclear processes, to imprinting conditions. We recently elucidated the genetic etiology in a large cohort of 74 children SGA-SS (Toni L et al, Horm Res Pediat 2024; 97(1): 40-52). Of these, 49 have already completed five years of daily GH therapy.Aim: To analyze 5...

hrp0098fc7.4 | GH and IGFs | ESPE2024

Growth Hormone Response to Glucagon Stimulation Test in Transitional Age

Fava Daniela , Vanorio Barbara , Santucci Chiara , Parodi Stefano , Pepe Alessia , Repetto Agnese , Caridi Claudia , Acquarone Lucia , Data Erica , Merlo Silvia , Napoli Flavia , Tedesco Caterina , Angelelli Alessia , Panciroli Marta , Casalini Emilio , Di Iorgi Natascia , Maghnie Mohamad

Context: In the diagnosis of permanent GH deficiency (GHD) during the transition phase, the 2019 AACE guidelines recommended peak GH-cutoffs of ≤3µg/L and ≤1µg/L for the glucagon test (GST), while a recent investigation identified a value <5.8μg/L as a suitable gold standard (Fava et al, Journal of Clinical Endocrinology and Metabolism, 2024). However, the clinical applicability of this cutoff remains to be confirmed and the potential c...

hrp0098p1-87 | Pituitary, Neuroendocrinology and Puberty 1 | ESPE2024

Phenotypic characteristic of a large cohort of pediatrics Argentine patients with PSIS. High Prevalence of Mutations in ROBO1 gene

Isabel Di Palma María , Plomer Paula , Marino Roxana , Perez Garrido Natalia , Belgorosky Alicia , Ramirez Pablo , Manuel Lazatti Juan , Inés Perez Millán María , Perticarari Catalina , Martinez Mayer Julián , Ciaccio Marta

Introduction: Pituitary stalk interruption syndrome (PSIS) is a rare congenital disorder characterized by absent, thin, or interrupted pituitary stalk, absent or ectopic neurohypophysis, and hypoplasia or aplasia of the adenohypophysis. It often accompanies midline abnormalities and diverse endocrine dysfunction, with its etiology largely unknown. Recent reports have linked mutations in the ROBO1 gene to PSIS.Aim: To des...

hrp0098p1-92 | Sex Endocrinology and Gonads 1 | ESPE2024

Phenotypic spectrum of WT1 gene variants in DSD

Celeste Mattone María , Turizo Carmen , Pérez Garrido Natalia , Gil Silvia , Cesar Ramírez Pablo , Roxana Marino , Laura Galluzzo Mutti María , Belgorosky Alicia , Ciaccio Marta , Berensztein Esperanza , Guercio Gabriela , Costanzo Mariana

Background: Wilms' Tumor Suppressor Gene 1 (WT1) plays an essential role in urogenital and kidney development. Germline variants in WT1 are associated with life-threatening glomerulopathy, disorders of gonadal development in both 46,XY and 46,XX individuals, Wilms tumor, and gonadal malignancies. Phenotypic overlap among 46,XY affected subjects has been frequently observed and there is still scarce information regarding renal involvement...

hrp0098p1-207 | Thyroid 2 | ESPE2024

Newborn screening for congenital hypothyroidism and re-screening at two weeks of life in infants born to mothers with thyroid diseases.

Vincenzi Gaia , Cristina Vigone Maria , Cavarzere Paolo , Palma Lorella , Camilot Marta , Teofoli Francesca , Amicosante Riccardo , Rotondi Daniela , Cereda Cristina , Cappelletti Laura , Alberti Luisella , Barera Graziano , De Angelis Simona , Olivieri Antonella

Background: The benefit of re-screening at 15 days of life in infants born to mothers with thyroid diseases (TD+) is a debated issue. In Italy, all the 16 newborn screening (NBS) laboratories use TSH measurement on dried blood spot as primary screening test for primary congenital hypothyroidism (CH) and adopt a 2-screen strategy in special categories of infants at risk of delayed TSH rise (preterm birth, admission to NICU, extra-thyroidal malformations, twinni...

hrp0098p1-216 | Bone, Growth Plate and Mineral Metabolism 3 | ESPE2024

Characterization of a large cohort of 99 argentinian patients with hereditary hypophosphatemic rickets (HHR) followed in a single pediatric tertiary center

Viterbo Gisela , Del Pino Mariana , Aziz Mariana , Abbate Silvina , Perez Garrido Natalia , Ramirez Pablo , Saraco Nora , Tesan Fiorella , Ciaccio Marta , Gabriela Obregón María , Fano Virginia , Belgorosky Alicia , Marino Roxana

Background: Hereditary hypophosphatemic rickets (HHR) comprises a group of rare disorders characterized by renal phosphate wasting and impaired vitamin D metabolism. Numerous genetic defects can underlie this condition, with the X-linked dominant form (XLHR) being the most prevalent (1 in 20,000 individuals) resulting from inactivating variants in the PHEX gene.Aim: To characterize a large cohort of 99 argentini...

hrp0098p2-205 | Multisystem Endocrine Disorders | ESPE2024

Congenital disorders of glycosylation (CDG): Endocrinological features in a case of twin siblings with a ALG1 gene defect.

Quarracino Malena , Vaiani Elisa , Inés Perez Millán María , Martinez Mayer Julián , Perticarari Catalina , Gallo Adolfo , Cervio Carolina , Isabel Di Palma María , Belgorosky Alicia , Viterbo Gisela , Ciaccio Marta

Introduction: Congenital disorders of glycosylation (CDG) are metabolic conditions resulting from defects in the glycosylation pathway. In addition to the primary neurological symptoms, other possible clinical findings may include distinctive coagulation abnormalities, as well as hepatic, gastrointestinal and, less frequently, hormonal disorders. The ALG1 gene defect is the third most prevalent CDG and compromises β-1,4 mannosyltransferase activity, which...

hrp0095p1-241 | Diabetes and Insulin | ESPE2022

3 Screen ICA TM Elisa - A New Tool for Identify Pre-Clinical Diabetes in First-Degree Relatives of Patients with Type 1 Diabetes (Pre-D1Abetes Study)

Noiszewska Klaudyna , Bossowski Artur , Zasim Aneta , Jamiołkowska-Sztabkowska Milena , Polkowska Agnieszka , Mazur Artur , Brzuszek Marta , Fichna Piotr , Niechciał Elżbieta , Szalecki Mieczysław , Wysocka-Mincewicz Marta , Myśliwiec Małgorzata , Żalińska Magdalena , Szmigierko-Kawko Małgorzata , Noczyńska Anna , Zubkiewicz-Kucharska Agnieszka , Chobot Agata , Górska-Flak Karolina , Ochab Agnieszka , Szadkowska Agnieszka , Wyka Krystyna , Pietrzak Iwona , Pilecki Olgierd , Jarosz-Chobot Przemysława , Rusak Ewa , Beń-Skowronek Iwona , Sieniawska Joanna , Szypowska Agnieszka , Nazim Joanna , Walczak Mieczysław , Jóźwa Anita , Marcinkiewicz Katarzyna , Powell Michael , Amoroso Marie , Rees Smith Bernard , Furmaniak Jadwiga

Background and Aims: A pre-clinical stage of type 1 diabetes (T1D) often precedes by many years the overt clinical symptoms. Diagnosis during this period is often difficult and is based on the presence of specific islet autoantibodies in the subject's blood. First-degree relatives of patients with T1D were tested using the 3 Screen ICA TM ELISA (RSR Ltd) for combined testing for autoantibodies to GAD65 (glutamic acid decarboxylase, 65kDa isoform), ZnT8 (z...

hrp0095p1-545 | Pituitary, Neuroendocrinology and Puberty | ESPE2022

X-Linked Central Precocious Puberty Associated with MECP2 defects

Canton Ana , Tinano Flavia , Guasti Leonardo , Montenegro Luciana , Ryan Fiona , Shears Deborah , Edna Melo Maria , Gomes Larissa , Piana Mariana , Brauner Raja , Espino Rafael , Escribano-Muñoz Arancha , Paganoni Alyssa , Korbonits Marta , Eduardo Seraphim Carlos , Faria Aline , Costa Silvia , Cristina Krepischi Ana , Jorge Alexander , David Alessia , Argente Jesús , Mendonca Berenice , Brito Vinicius , Howard Sasha , Claudia Latronico Ana

Background: Genetic causes of central precocious puberty (CPP) has been increasingly recognized, extending our knowledge of the triggering factors of human pubertal timing. Distinct etiologies remain to be elucidated in sporadic and familial cases. Methyl-CpG-binding protein 2 (MECP2) is a chromatin-associated protein that can activate or repress gene transcription, playing a role in neuronal maturation. It is encoded by MECP2 gene located at chromoso...